recently , behavioral and electrophysiologic ameliorations of he have been reported to occur in animal models of fulminant hepatic failure ( fhf ) and , in uncontrolled studies , in a majority of patients with fhf or cirrhosis following the intravenous administration of the benzodiazepine ( bz ) receptor antagonist , flumazenil .
C1372996
benzodiazepine
C0016293
flumazenil